Steroid hormone metabolizing enzymes in benign and malignant human bone tumors

Expert Opinion on Drug Metabolism and Toxicology

Volumn 6, Issue 4, 2010, Pages 427-437

  Svoboda, Martin ^a   Hamilton, Gerhard ^b   Thalhammer, Theresia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ludwig Boltzmann Cluster of Translational Oncology   (Austria)

Author keywords

Aromatase; Bone tumors; Estrogen; Estrogen sulfotransferase; Giant cell tumors; Intracrine; Osteosarcoma; Sex steroid hormones; Steroid dehydrogenase; Steroid sulfatase

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTENEDIONE; AROMATASE; CCAAT ENHANCER BINDING PROTEIN; COLECALCIFEROL; CYTOCHROME P450 17; ENZYME; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE SULFATE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PRASTERONE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STEROID 5ALPHA REDUCTASE; STEROID HORMONE METABOLIZING ENZYME; STERYL SULFATASE; SULFOTRANSFERASE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANEURYSMAL BONE CYST; APOPTOSIS; BIOTRANSFORMATION; BONE CELL; BONE CYST; BONE MASS; BONE MATURATION; BONE TURNOVER; CELL DIFFERENTIATION; CELL SURVIVAL; ESTROGEN SYNTHESIS; HOMEOSTASIS; HORMONE METABOLISM; HUMAN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOBLASTOMA; OSTEOCLAST; OSTEOCLASTOMA; OSTEOLYSIS; OSTEOSARCOMA; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

BONE AND BONES; BONE NEOPLASMS; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE;

EID: 77949895509     PISSN: 17425255     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425251003592129     Document Type: Review

References (89)

1. Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol (Paris). 2003;64:95-107
2. Matsuo K, Irie N. Osteoclast-osteoblast communication. Arch Biochem Biophys 2008;473:201-209
3. Sims NA, Gooi JH. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008:444-451
4. Henriksen K, Neutzsky-Wulff AV, Bonewald LF, et al. Local communication on and within bone controls bone remodeling. Bone 2009;44:1026-1033
5. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508-1514
6. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003;86:225-230
7. Gallagher JC. Advances in bone biology and new treatments for bone loss. Maturitas. 2008;60:65-69
8. Vanderschueren D, Gaytant J, Boonen S, et al. Androgens and bone. Curr Opin Endocrinol Diabetes Obes 2008;15:250-254
9. Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol 2003;41:217-221
10. Grumbach MM. Mutations in the synthesis and action of estrogen: the critical role in the male of estrogen on pubertal growth, skeletal maturation, and bone mass. Ann NY Acad Sci 2004;1038:7-13
11. Compston JE. Sex steroids and bone. Physiol Rev 2001;81:419-447
12. Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res 2002;57:385-409
13. Syed F, Khosla S. Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun 2005;328:688-696
14. Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol 2007;143:31-48
15. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-253
16. Wada T, Nakashima T, Hiroshi N, et al. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12:17-25
17. Ando K, Mori K, Rédini F, et al. RANKL/RANK/OPG: key therapeutic target in bone oncology. Curr Drug Discov Technol 2008;5:263-268
18. Michael H, Härkönen PL, Väänänen HK, et al. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 2005;20:2224-2232
19. Centrella M, Christakos S, McCarthy TL. Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression. Gene 2004;342(1):13-24
20. Ray P, Ghosh SK, Zhang D-H, Ray A. Repression of interleukin-6 gene expression by 17beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kB by the estrogen receptor. FEBS Lett 1997;409:79-85
21. McCarthy TL, Centrella M. Local IGF-I expression and bone formation. Growth Horm IGF Res 2001;11:213-219
22. Teplyuk NM, Zhang Y, Lou Y, et al. The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. Mol Endocrinol 2009;23:849-861
23. Weber KL. What's new in musculoskeletal oncology. J Bone Joint Surg Am 2005;87:1400-1410
24. Shirtcliff EA, Dahl RE, Pollak SD. Pubertal development: correspondence between hormonal and physical development. Child Dev 2009;80:327-337
25. Rochira V, Carani C. Aromatase deficiency in men: a clinical perspective. Nat Rev Endocrinol 2009;5:559-568
26. Grumbach MM. Estrogen, bone, growth and sex: a sea change in conventional wisdom. J Pediatr Endocrinol Metab 2000;13:1439-1455
27. Weber K, Damron TA, Frassica FJ, et al. Malignant bone tumors. Instr Course Lect 2008;57:673-688
28. O'Day K, Gorlick R. Novel therapeutic agents for osteosarcoma. Expert Rev Anticancer Ther 2009;9:511-523
29. Cerase A, Priolo F. Skeletal benign bone-forming lesions. Eur J Radiol 1998;27:S91-7
30. Zehetgruber H, Bittner B, Gruber D, et al. Prevalence of aneurysmal and solitary bone cysts in young patients. Clin Orthop Relat Res 2005;439:136-143
31. White LM, Kandel R. Osteoid-producing tumors of bone. Semin Musculoskelet Radiol 2000;4:25-43
32. Dahlin DC, Cupps RE, Johnson EW Jr. Giant-cell tumor: a study of 195 cases. Cancer 1970;25:1061-1070
33. Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol 2009;21:338-344
34. Labrie F, Luu-The V, Bélanger A, et al. Is dehydroepiandrosterone a hormone? J Endocrinol 2005;187:169-196
35. Grow DR. Metabolism of endogenous and exogenous reproductive hormones. Obstet Gynecol Clin North Am 2002;29:425-436
36. Sasano H, Suzuki T, Miki Y, et al. Intracrinology of estrogens and androgens in breast carcinoma. J Steroid Biochem Mol Biol 2008;108:181-185
37. Miller WL. Steroidogenic enzymes. Endocr Dev 2008;13:1-18
38. Bruch HR, Wolf L, Budde R, et al. Androstenedione metabolism in cultured human osteoblast-like cells. J Clin Endocrinol Metab 1992;75:101-105
39. Saito H, Yanaihara T. Steroid formation in osteoblast-like cells. J Int Med Res 1998;26:1-12
40. Sasano H, Nagasaki S, Miki Y, et al. New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase. Ann NY Acad Sci 2009;1155:76-79
41. Pasqualini JR. The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta. 2004;1654:123-143
42. Janssen JM, Bland R, Hewison M, et al. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function. J Cell Biochem 1999;75:528-537
43. Muir M, Romalo G, Wolf L, et al. Estrone sulfate is a major source of local estrogen formation in human bone. J Clin Endocrinol Metab 2004;89:4685-4692
44. Labrie F, Simard J, Luu-The V, et al. Structure and tissue-specific expression of 3 beta-hydroxysteroid dehydrogenase/ 5-ene-4-ene isomerase genes in human andrat classical and peripheral steroidogenic tissues. J Steroid Biochem Mol Biol 1992;41:421-435
45. Simard J, Ricketts ML, Gingras S, et al. Molecular biology of the 3beta-hydroxysteroid dehydrogenase/ delta5-delta4 isomerase gene family. Endocr Rev 2005;26:525-582
46. Doggrell SA. New findings with old drugs for osteoporosis. Expert Opin Pharmacother 2009;10:513-516
47. McCarthy TL, Hochberg RB, Labaree DC, Centrella M. 3-ketosteroid reductase activity and expression by fetal rat osteoblasts. J Biol Chem 2007;282:34003-34012
48. de Gooyer ME, Kleyn GT, Smits KC, et al. Tibolone: a compound with tissue specific inhibitory effects on sulfatase. Mol Cell Endocrinol 2001;183(1-2):55-62
49. Falany JL, Macrina N, Falany CN. Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 2004;88:383-391
50. Kuwano Y, Fujikawa H, Watanabe A, et al. 3Beta-hydroxysteroid dehydrogenase activity in human osteoblast-like cells. Endocr J 1997;44:847-853
51. Dong Y, Qiu QQ, Debear J, et al. 17Beta-hydroxysteroid dehydrogenases in human bone cells. J Bone Miner Res 1998;13:1539-1546
52. Fujikawa H, Okura F, Kuwano Y, et al. Steroid sulfatase activity in osteoblast cells. Biochem Biophys Res Commun 1997;231:42-47
53. Jakob F, Siggelkow H, Homann D, et al. Local estradiol metabolism in osteoblastand osteoclast-like cells. J Steroid Biochem Mol Biol 1997;61:167-174
54. Baker ME. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action. Mol Cell Endocrinol 2001;171:211-215
55. Luu-The V. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 2001;76:143-151
56. Meier M, Möller G, Adamski J. Perspectives in understanding the role of human 17beta-hydroxysteroid dehydrogenases in health and disease. Ann NY Acad Sci 2009;1155:15-24
57. Penning TM, Byrns MC. Steroid hormone transforming aldo-keto reductases and cancer. Ann NY Acad Sci 2009;1155:33-42
58. Stanbrough M, Bubley GJ, Ross K, et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006;66:2815-2825
59. Feix M, Wolf L, Schweikert HU. Distribution of 17beta-hydroxysteroid dehydrogenases in human osteoblast-like cells. Mol Cell Endocrinol 2001;171:163-164
60. Osawa Y, Higashiyama T, Fronckowiak M, et al. Aromatase. J Steroid Biochem 1987;27:781-789
61. Simpson ER. Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med 2004;22:11-23
62. Nawata H, Tanaka S, Tanaka S, et al. Aromatase in bone cell: association with osteoporosis in postmenopausal women. J Steroid Biochem Mol Biol 1995;53:165-174
63. Santen RJ, Brodie H, Simpson ER, et al. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev 2009;30:343-375
64. Yanase T, Suzuki S, Goto K, et al. Aromatase in bone: roles of vitamin D3 and androgens. J Steroid Biochem Mol Biol 2003;86:393-397
65. Pino AM, Rodríguez JM, Ríos S, et al. Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin. J Endocrinol 2006;191:715-725
66. Ghosh D. Human sulfatases: a structural perspective to catalysis. Cell Mol Life Sci 2007;64:2013-2022
67. Reed MJ, Purohit A, Woo LW, et al. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev 2005;26:171-202
68. Iwamori M. Estrogen sulfatase. Methods Enzymol 2005;400:293-302
69. Falany CN. Enzymology of human cytosolic sulfotransferases. FASEB J 1997;11:206-216
70. Blanchard RL, Freimuth RR, Buck J, et al. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 2004;14:199-211
71. Adjei AA, Weinshilboum RM. Catecholestrogen sulfation: possible role in carcinogenesis. Biochem Biophys Res Commun 2002;292:402-408
72. Svoboda M, Thalhammer T, Aust S, et al. Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors. J Surg Oncol 2007;95:572-581
73. Qian YM, Sun XJ, Tong MH, et al. Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation. Endocrinology 2001;142:5342-5350
74. Otterness DM, Weinshilboum R. Human dehydroepiandrosterone sulfotransferase: molecular cloning of cDNA and genomic DNA. Chem Biol Interact 1994;92:145-159
75. Issa S, Schnabel D, Feix M, et al. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. J Clin Endocrinol Metab 2002;87:5401-5407
76. Kushlinskii NE, Degtiar' VG, Babkina TV, et al. Androgen metabolism in malignant and benign bone tumors. Bull Exp Biol Med 2000;1:78-80
77. Imai Y, Nakamura T, Matsumoto T, et al. Molecular mechanisms underlying the effects of sex steroids on bone and mineral metabolism. J Bone Miner Metab 2009;27:127-130
78. Miki Y, Suzuki T, Hatori M, et al. Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone 2007;40:876-887
79. Solakidi S, Psarra AM, Sekeris CE. Differential distribution of glucocorticoid and estrogen receptor isoforms: localization of GRbeta and ERalpha in nucleoli and GRalpha and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. J Musculoskelet Neuronal Interact 2007;7:240-245
80. Dohi O, Hatori M, Suzuki T, et al. Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma. Cancer Sci 2008;99:518-523
81. Saraiva PP, Teixeira SS, Conde SJ, et al. The importance of hormone receptor analysis in osteosarcoma cells growth submitted to treatment with estrogen in association with thyroid hormone. Cell Biochem Funct 2008;26:107-110
82. Sasano H, Uzuki M, Sawai T, et al. Aromatase in human bone tissue. J Bone Miner Res 1997;12:1416-1423
83. Shozu M, Simpson ER. Aromatase expression of human osteoblast-like cells. Mol Cell Endocrinol 1998;139:117-129
84. Olivera P, Perez E, Ortega A, et al. Estrogen receptor expression in giant cell tumors of the bone. Hum Pathol 2002;33:165-169
85. Oursler MJ, Pederson L, Fitzpatrick L, et al. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci USA 1994;91:5227-5231
86. Pasqualini JR, Chetrite GS. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 2005;93:221-236
87. Stanway SJ, Delavault P, Purohit A, et al. Steroid sulfatase: a new target for the endocrine therapy of breast cancer. Oncologist 2007;12:370-374
88. Aidoo-Gyamfi K, Cartledge T, Shah K, et al. Estrone sulfatase and its inhibitors. Anticancer Agents Med Chem 2009;9:599-612
89. Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003;544:9-41